A volunteer involved in the trial of the Corona vaccine being developed by AstraZeneca and Oxford University has died. Brazilian Health Authority Anvisa gave this information on Wednesday. However, vaccine trials will not be stopped despite Volunteer’s death. No further information has been given about this due to medical confidentiality.
According to the Federal University of São Paulo (which is undergoing a third phase trial of the corona virus vaccine in Brazil), the volunteer who died was from Brazil, but no information has been given about where he lived. AstraZeneca’s stock has fallen by 1.7 percent due to the news of Volunteer’s death.
The Corona epidemic in Brazil has killed more than 1,54,000 people. Brazil is the second most affected country in the death of Corona patients after the US. Brazil is also the third most infected country in the world in terms of number of corona infections. In this case, America and India are in second place respectively.
Rapid work is going on to prepare the Corona virus vaccine and medicine worldwide. Many experts have expressed hope that the vaccine may be ready within the next two and a half months. But during this time, questions are also being raised about the Corona vaccine and medicine.